Osemitamab Not Yet Recruiting Phase 3 Trials for Gastric Cancer / Gastroesophageal Junction Cancer / Advanced Malignant Neoplasm Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT06093425Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma